We are live on ! Find out more
SGM

Seven Grand Managers Portfolio holdings

AUM $1.5B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+11.24%
1 Year Est. Return
+57.16%
3 Year Est. Return
+233.02%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.5B
AUM Growth
+$183M
Cap. Flow
+$155M
Cap. Flow %
10.34%
Top 10 Hldgs %
42.84%
Holding
214
New
76
Increased
20
Reduced
18
Closed
47

Top Buys

1
LHX icon
L3Harris
LHX
+$96.1M
2
MDLN
Medline Inc
MDLN
+$59.6M
3
LRCX icon
Lam Research
LRCX
+$59M
4
ECHO
EchoStar
ECHO
+$57.4M
5
TSLA icon
Tesla
TSLA
+$53.6M

Top Sells

1
SNDK
Sandisk
SNDK
+$84.7M
2
TMUS icon
T-Mobile US
TMUS
+$40.6M
3
SOFI icon
SoFi Technologies
SOFI
+$39.3M
4
MDT icon
Medtronic
MDT
+$38.4M
5
COHR icon
Coherent
COHR
+$36.9M

Sector Composition

1 Industrials 23.49%
2 Healthcare 18.53%
3 Technology 17.09%
4 Energy 11.6%
5 Consumer Discretionary 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LFST icon
126
Lifestance Health
LFST
$4.31B
$1.59M 0.11%
+250,000
New +$1.74M
GTY
127
Getty Realty Corp
GTY
$2.18B
$1.59M 0.11%
+50,000
New +$1.56M
PXED
128
Phoenix Education Partners
PXED
$1.1B
$1.57M 0.11%
50,000
– –
PICS
129
PicS N.V.
PICS
$1.48B
$1.57M 0.1%
+150,000
New +$2.2M
GENB
130
Generate Biomedicines
GENB
$1.75B
$1.56M 0.1%
+125,000
New +$1.53M
SM icon
131
SM Energy
SM
$7.24B
$1.56M 0.1%
+50,000
New +$1.14M
MDU icon
132
MDU Resources
MDU
$4.42B
$1.55M 0.1%
75,000
-75,000
-50% -$1.54M
CTMX icon
133
CytomX Therapeutics
CTMX
$798M
$1.53M 0.1%
+325,000
New +$1.65M
XZO
134
Exzeo Group
XZO
$1.52B
$1.47M 0.1%
100,000
-50,000
-33% -$888K
FLOC
135
Flowco Holdings
FLOC
$852M
$1.44M 0.1%
70,000
– –
IONQ icon
136
IonQ
IONQ
$13.1B
$1.44M 0.1%
50,000
– –
SMR icon
137
NuScale Power
SMR
$2.64B
$1.35M 0.09%
125,000
– –
COGT icon
138
Cogent Biosciences
COGT
$6.48B
$1.35M 0.09%
35,000
– –
JCAP
139
Jefferson Capital
JCAP
$1.21B
$1.35M 0.09%
+70,000
New +$1.48M
BRCB
140
Black Rock Coffee Bar Inc
BRCB
$173M
$1.29M 0.09%
100,000
– –
CURB
141
Curbline Properties
CURB
$3.53B
$1.29M 0.09%
+50,000
New +$1.28M
BCAX
142
Bicara Therapeutics
BCAX
$1.81B
$1.24M 0.08%
+62,500
New +$1.08M
GPOR icon
143
Gulfport Energy Corp
GPOR
$2.76B
$1.06M 0.07%
+5,000
New +$994K
SABS icon
144
SAB Biotherapeutics
SABS
$280M
$1.05M 0.07%
+275,000
New +$1.1M
UEC icon
145
Uranium Energy
UEC
$4.62B
$1.01M 0.07%
75,000
– –
INVX
146
Innovex International
INVX
$1.8B
$976K 0.07%
+40,000
New +$1M
LMRI
147
Lumexa Imaging Holdings
LMRI
$1.08B
$946K 0.06%
110,000
-535,500
-83% -$7.35M
NTST
148
NETSTREIT Corp
NTST
$2.15B
$942K 0.06%
+50,000
New +$963K
APC
149
ARKO Petroleum
APC
$987M
$895K 0.06%
+50,000
New +$926K
INR
150
Infinity Natural Resources
INR
$245M
$881K 0.06%
50,000
– –
4 5
6
7 8

Similar funds

CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
NPF
Norris Perne & French Grand Rapids, Michigan $1.5B AUM 19.93% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return

Seven Grand Managers's Q1 2026 Portfolio in Review

As of Q1 2026, Seven Grand Managers held 214 positions worth $1.5B, up 14% from $1.31B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Seven Grand Managers deployed $155M of net new capital in Q1 2026, opening 76 new positions and adding to 20 existing holdings. Its largest new stake was L3Harris: 275,000 shares worth $94.9M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Sandisk, an estimated $84.7M trimmed.

  • Seven Grand Managers's largest Q1 2026 buy was L3Harris: 275,000 shares worth $94.9M.
  • Seven Grand Managers added most to Medline Inc in Q1 2026, an estimated $59.6M increase.
  • Seven Grand Managers's biggest Q1 2026 reduction was Sandisk, cutting an estimated $84.7M.
  • Seven Grand Managers fully exited T-Mobile US in Q1 2026, selling an estimated $40.6M.
  • Seven Grand Managers's ten largest holdings make up 43% of its $1.5B portfolio in Q1 2026.
  • Seven Grand Managers opened 76 new positions and closed 47 in Q1 2026.
  • Seven Grand Managers's portfolio value rose 14% quarter-over-quarter to $1.5B.

Based on Seven Grand Managers's 13F filing for Q1 2026, filed 6 May 2026.